Delivery Order SPE2DR25D1104-SPE2DR26FK254
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a $67,062.44 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. The contract, which is a child award under a larger indefinite delivery contract vehicle, carries an ultimate completion date of September 29, 2025, and was competitively awarded with no set-aside designation. Performance will be executed from the company's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,091.40 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $59,501.28 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis, psoriasis, and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,505.16 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement...
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a $11,685 firm fixed price delivery order by the Defense Logistics Agency (DLA) on October 29, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. The contract, which carries no set-aside designation, was competitively awarded and is scheduled for completion by October 30, 2025. Performance will be executed from the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $54,357.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $64,327.41 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This firm fixed-price delivery order, issued on September 8, 2025, with completion targeted for September 9, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply contract, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $15,467.93 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of June 25, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $46,557.92 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitive award, which carries no set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The contract will be performed at...